Evidence map›Paper›PMID 42679502›Full record

ArticleThe journal of nutrition, health & aging2026

Impact of cocoa flavanols on blood pressure and vascular function: an updated systematic review and meta-analysis of randomized controlled trials.

Misato Sakuda, Kyoko Ito, Yuna Adaniya, Norikazu Watanabe, Li Han, Midori Natsume, Kentaro Nakamura

Abstract read
In one paragraph

Article in The journal of nutrition, health & aging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Misato SakudaHealth Science Research Unit, R&D Division, Meiji Co., Ltd., Tokyo, Japan.
Kyoko ItoHealth Science Research Unit, R&D Division, Meiji Co., Ltd., Tokyo, Japan.
Yuna AdaniyaHealth Science Research Unit, R&D Division, Meiji Co., Ltd., Tokyo, Japan.
Norikazu WatanabeYakujihou Marketing Jimusho Co., Ltd., Tokyo, Japan.
Li HanYakujihou Marketing Jimusho Co., Ltd., Tokyo, Japan.
Midori NatsumeHealth Science Research Unit, R&D Division, Meiji Co., Ltd., Tokyo, Japan.
Kentaro NakamuraHealth Science Research Unit, R&D Division, Meiji Co., Ltd., Tokyo, Japan. Electronic address: kentarou.nakamura@meiji.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

objectiveWhile elevated blood pressure is a major cardiovascular risk factor, a comprehensive evaluation of not only blood pressure but also vascular function is essential to evaluate the risk of cardiovascular diseases and the effectiveness of interventions. Cocoa flavanols may lower blood pressure by improving endothelial function, however evidence regarding vascular indices is limited, and findings remain inconsistent and not the latest. We conducted an updated systematic review and meta-analysis to comprehensively evaluate the effects of cocoa flavanol intake on blood pressure and vascular function.

methodsThis review was registered in UMIN-CTR (UMIN000059995), and we searched PubMed, Cochrane Library, Ichushi-Web, JDreamIII, ICTRP and UMIN-CTR for eligible randomized controlled trials up to December 8, 2025. Primary outcomes were systolic and diastolic blood pressure (SBP/DBP); secondary outcomes were flow-mediated dilation (FMD), pulse wave velocity (PWV), and ankle-brachial index (ABI). Mean differences (MD) with 95% confidence intervals (CIs) were pooled using a random-effects model. Risk of bias was assessed using a modified version of the Cochrane Risk of Bias 2 (RoB 2), and certainty of evidence was graded.

resultsTwenty-five studies (n = 1,167) included hypertensive and normotensive participants; daily cocoa flavanol doses ranged from 10.6 to 1,680 mg. Both SBP and DBP decreased significantly following cocoa flavanol intake (SBP: MD -2.734 mmHg, 95% CI [-3.446, -2.023]; DBP: MD -1.848 mmHg, 95% CI [-2.725, -0.971]). Significant improvements were also observed for FMD (MD 1.314%, 95% CI [1.043, 1.585]) and PWV (MD -0.200 m/s, 95% CI [-0.393, -0.007]), whereas ABI showed no significant change, with limited evidence from only two studies. Subgroup analyses were consistent for SBP/DBP in both hypertensive and normotensive participants. Dose-response analyses revealed a significant inverse association between SBP or DBP and flavanol intake, but did not identify clear dose thresholds within the examined intake range. Certainty was moderate for SBP; other outcomes were limited.

conclusionThese findings suggest that cocoa flavanol intake of 10.6-1,680 mg/day may modestly reduce blood pressure and may improve selected vascular function indices, although certainty for vascular outcomes remains limited.

Indexed as

Cocoa flavanolFlow mediated dilationHypertensionMeta-analysisPulse wave velocity

Identifiers

PMID42679502
PMCPMC13563239

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.